NXTM - NxStage Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenue 393,941 366,378 336,123 301,501
Cost of Revenue 225,353 213,893 204,452 185,598
Gross Profit 168,588 152,485 131,671 115,903
Operating Expenses
Research Development 39,608 31,032 26,237 22,635
Selling General and Administrative 135,831 125,238 119,863 115,455
Non Recurring - - - -
Others - - - -
Total Operating Expenses 400,792 370,163 350,552 323,688
Operating Income or Loss -6,851 -3,785 -14,429 -22,187
Income from Continuing Operations
Total Other Income/Expenses Net -8,619 -2,430 -754 -873
Earnings Before Interest and Taxes -6,851 -3,785 -14,429 -22,187
Interest Expense -756 -1,000 -1,115 -863
Income Before Tax -15,470 -6,215 -15,183 -23,060
Income Tax Expense -145 1,102 1,077 1,253
Minority Interest -177 675 1,913 1,088
Net Income From Continuing Ops -15,325 -7,317 -16,260 -24,313
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income -13,992 -4,771 -15,342 -23,946
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares -14,473 -4,771 -15,342 -23,946